Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.